Extended Clopidogrel Therapy Beyond 12 Months and Long-Term Outcomes in Patients With Diabetes Mellitus Receiving Coronary Arterial Second-Generation Drug-Eluting Stents-Reference-Cited by-同舟云学术

Extended Clopidogrel Therapy Beyond 12 Months and Long-Term Outcomes in Patients With Diabetes Mellitus Receiving Coronary Arterial Second-Generation Drug-Eluting Stents

Published:2018-09 Issue:5 Volume:122 Page:705-711
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Cho Sung Woo,Park Kyutae,Ahn Jong-Hwa,Park Taek Kyu,Lee Su Yeon,Kim Jihoon,Lee Joo Myung^ORCID,Yang Jeong Hoon^ORCID,Song Young Bin,Choi Jin-Ho,Choi Seung-Hyuk,Gwon Hyeon-Cheol,Lee Sang Hoon,Ahn Joonghyun,Carriere K.C.,Hahn Joo-Yong

Funder

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Diabetes mellitus: a hypercoagulable state;Carr;J Diabetes Complications,2001

2. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention;Angiolillo;Am J Cardiol,2006

3. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions;Brar;J Am Coll Cardiol,2008

4. Long-term outcomes in patients with diabetes mellitus related to prolonging clopidogrel more than 12 months after coronary stenting;Thukkani;J Am Coll Cardiol,2015

5. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the efficacy of xience/promus versus cypher to reduce late loss after stenting (EXCELLENT) randomized, multicenter study;Gwon;Circulation,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus;The American Journal of Cardiology;2021-03

2. Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients;Journal of Korean Medical Science;2021

3. Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus;Frontiers in Cardiovascular Medicine;2020-11-27

4. Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline;Cardiovascular Drugs and Therapy;2020-06-29

5. Malnutrition and Clopidogrel Non-Use Worsen Prognosis of Critical Limb Ischemia Patients After Revascularization;Circulation Reports;2020-02-10